|
Market Closed -
Other stock markets
|
After hours 08:00:00 pm | |||
| 485.39 USD | -2.24% |
|
482.70 | -0.55% |
| Jul. 09 | RBC Capital Adjusts Vertex Pharmaceuticals Price Target to $577 From $570 | MT |
| Jul. 08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| Market Cap | 123B 108B 99.39B 91.8B 174B 11,750B 177B 1,188B 466B 5,788B 463B 452B 19,899B | P/E 2026 * |
27.9x | P/E 2027 * | 24.8x |
|---|---|---|---|---|---|
| Enterprise Value | 110B 95.83B 88.39B 81.64B 155B 10,449B 158B 1,056B 415B 5,148B 411B 402B 17,696B | EV / Sales 2026 * |
8.39x | EV / Sales 2027 * | 7.32x |
| Free-Float |
99.8% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | -2.24% | ||
| 1 week | -8.08% | ||
| Current month | -2.28% | ||
| 1 month | +11.40% | ||
| 3 months | +11.26% | ||
| 6 months | +4.64% | ||
| Current year | +7.07% |
| 1 week | 482.11 |  | 533.67 |
| 1 month | 439.5 | | 533.67 |
| Current year | 412.27 | | 533.67 |
| 1 year | 362.5 | | 533.67 |
| 3 years | 340.2 | | 533.67 |
| 5 years | 176.36 | | 533.67 |
| 10 years | 71.46 | | 533.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 2020-03-31 | |
Charles Wagner
DFI | Director of Finance/CFO | 58 | 2019-04-09 |
Mark Bunnage
CTO | Chief Tech/Sci/R&D Officer | - | 2021-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 1997-12-31 |
Jeffrey Leiden
CHM | Chairman | 70 | 2012-04-30 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 2015-06-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Jul. 01 | Sell | Director | -1,500 | 0.0006% | ||
| Jul. 01 | Sell | Executive/Senior Manager | -1,541 | 0.0006% | ||
| Jun. 30 | Sell | General Counsel | -828 | 0.0003% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.24% | -8.08% | +1.22% | +40.91% | 126B | |
| -2.33% | -2.09% | +50.33% | +162.29% | 1,085B | |
| -0.82% | -2.30% | +62.97% | +61.11% | 624B | |
| -0.73% | -4.98% | +27.22% | +84.46% | 442B | |
| +0.33% | -1.17% | +27.98% | +26.90% | 332B | |
| -0.02% | -2.85% | +25.27% | +44.88% | 282B | |
| -3.89% | -11.22% | +20.78% | +26.07% | 277B | |
| +0.66% | -1.42% | -29.26% | -39.30% | 217B | |
| -0.06% | -2.88% | +20.98% | +61.70% | 196B | |
| -3.72% | -1.10% | +13.35% | +71.53% | 167B | |
| Average | -1.03% | -4.01% | +22.08% | +54.05% | 374.8B | |
| Weighted average by Cap. | -0.63% | -3.32% | +34.22% | +80.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.05B 11.42B 10.53B 9.73B 18.46B 1,245B 18.77B 126B 49.41B 613B 49.01B 47.94B 2,108B | 14.31B 12.51B 11.54B 10.66B 20.23B 1,365B 20.57B 138B 54.16B 672B 53.72B 52.55B 2,311B |
| Net income | 4.48B 3.92B 3.61B 3.34B 6.33B 427B 6.44B 43.16B 16.95B 210B 16.81B 16.45B 723B | 5.06B 4.43B 4.09B 3.77B 7.16B 483B 7.28B 48.82B 19.17B 238B 19.01B 18.6B 818B |
| Net Debt | -13.64B -11.93B -11B -10.16B -19.28B -1,300B -19.6B -131B -51.62B -641B -51.2B -50.08B -2,202B | -18.47B -16.15B -14.9B -13.76B -26.11B -1,761B -26.55B -178B -69.9B -868B -69.33B -67.82B -2,983B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | $485.39 | -2.24% | 1,430,186 |
| 26-07-09 | $496.50 | -0.39% | 2,107,282 |
| 26-07-08 | $498.43 | -4.56% | 2,287,222 |
| 26-07-07 | $522.25 | -1.39% | 2,292,906 |
| 26-07-06 | $529.59 | +0.29% | 1,515,703 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
